ZS Pharma, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
ZS Pharma, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$35.35 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2015-11-09
- ZS Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2015-09-30 was -$35.35M.
- ZS Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2015-06-30 was -$32.60M.
- ZS Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2015-03-31 was -$21.95M.
- ZS Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2014-12-31 was -$20.32M.
- ZS Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2014 was -$64.04M.
- ZS Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2013 was -$33.60M.
- ZS Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2012 was -$10.28M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2015-09-30 | -$35.35M 10-Q · filed 2015-11-09 | -$67.95M derived: sum of 2 quarters · filed 2015-11-09 | -$89.90M 10-Q · filed 2015-11-09 | -$110.21M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | -$32.60M 10-Q · filed 2015-08-06 | -$54.55M 10-Q · filed 2015-08-06 | -$74.86M derived: sum of 3 quarters · filed 2015-08-06 | -$91.73M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-03-31 | -$21.95M 10-Q · filed 2015-05-11 | -$42.26M derived: sum of 2 quarters · filed 2015-05-11 | -$59.12M derived: sum of 3 quarters · filed 2015-11-09 | -$75.42M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-12-31 | -$20.32M 10-K · filed 2015-03-13 | -$37.18M derived: sum of 2 quarters · filed 2015-11-09 | -$53.48M derived: sum of 3 quarters · filed 2015-11-09 | -$64.04M 10-K · filed 2015-03-13 |
| 2014-09-30 | -$16.86M 10-Q · filed 2015-11-09 | -$33.16M derived: sum of 2 quarters · filed 2015-11-09 | -$43.73M 10-Q · filed 2015-11-09 | -$55.39M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | -$16.30M 10-Q · filed 2015-08-06 | -$26.87M 10-Q · filed 2015-08-06 | -$38.53M derived: sum of 3 quarters · filed 2015-08-06 | -$47.92M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | -$10.57M 10-Q · filed 2015-05-11 | -$22.23M derived: sum of 2 quarters · filed 2015-05-11 | -$31.62M derived: sum of 3 quarters · filed 2015-05-11 | -$38.94M derived: sum of 4 quarters · filed 2015-05-11 |
| 2013-12-31 | -$11.66M 10-K · filed 2015-03-13 | -$21.06M derived: sum of 2 quarters · filed 2015-03-13 | -$28.37M derived: sum of 3 quarters · filed 2015-03-13 | -$33.60M 10-K · filed 2015-03-13 |
| 2013-09-30 | -$9.39M 10-K · filed 2015-03-13 | -$16.71M derived: sum of 2 quarters · filed 2015-03-13 | -$21.93M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -$7.32M 10-K · filed 2015-03-13 | -$12.54M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$5.23M 10-K · filed 2015-03-13 | |||
| 2012-12-31 | -$10.28M 10-K · filed 2015-03-13 |